Table. 1.

Patient characteristics

Variable No-DJ (n=25) DJ (n=17) P-value
Age (yr) 48.1±12.9 52.2±8.8 0.228
Female sex 8 (32.0) 6 (35.3) 0.824
Body mass index (kg/m2) 23.0±3.9 23.4±2.9 0.739
Dialysis duration (mo) 37.9±44.6 43.0±44.4 0.735
Cause of ESRD 0.152
Hypertensive 7 (28.0) 2 (11.8)
Diabetes 7 (28.0) 6 (35.3)
Glomerulonephritis 7 (28.0) 5 (29.4)
Polycystic kidney 1 (4.0) 4 (23.5)
Unknown 3 (12.0) 0
Pre-emptive 3 (12.0) 2 (11.8) 0.982
Dialysis type 0.549
Hemodialysis 11 (50.0) 6 (40.0)
Peritoneal dialysis 11 (50.0) 9 (60.0)
Donor type 0.122
Living 19 (76.0) 16 (94.1)
Deceased 6 (24.0) 1 (5.9)
Duration of Foley catheter (day) 9.7±3.6 13.1±7.1 0.085
Mean trough level of tacrolimus
At 1 month post-KT (ng/mL) 7.9±1.5 8.0±1.4 0.849
At 6 months post-KT (ng/mL) 6.5±1.3 7.4±1.5 0.069
At 12 months post-KT (ng/mL) 6.3±1.2 6.8±1.3 0.239
Mycophenolate mofetil dose (mg/day) 940±219 970±214 0.657
ATG induction 0 5 (29.4) 0.004
Hepatitis B virus carrier 5 (20.0) 1 (5.9) 0.199
ABO incompatible 4 (16.0) 6 (35.3) 0.150
Cross match positivity (flow) 0 2 (11.8) 0.079
Donor specific antibody (+) 1 (4.0) 5 (29.4) 0.021
HLA mismatch >3 6 (24.0) 6 (35.3) 0.426

Values are presented as mean±standard deviation or number (%).

DJ, double-J; ESRD, end-stage renal disease; KT, kidney transplant; ATG, antithymocyte globulin; HLA, human leukocyte antigen.

Korean J Transplant 2021;35:41~47 https://doi.org/10.4285/kjt.20.0050
© Korean Journal of Transplantation